Arcus Biosciences
RCUS
RCUS
64 hedge funds and large institutions have $274M invested in Arcus Biosciences in 2018 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $293M → $274M (-$18.6M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
64
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$27.9M | |
| 2 | +$4.65M | |
| 3 | +$4.19M | |
| 4 |
BlackRock
New York
|
+$3.86M |
| 5 |
JPMorgan Chase & Co
New York
|
+$3.13M |
Top Sellers
| 1 | -$4.35M | |
| 2 | -$3.79M | |
| 3 | -$2.19M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$2.02M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$1.6M |